You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Madeleine covers PCR, nucleic acid amplification, and sample prep technologies for GenomeWeb and 360Dx.
The firm's over-the-counter claim submission is delayed because it has been unable to find the required number of positive cases among asymptomatic people.
With $1.2 billion in funding earmarked for more than 40 projects, the portfolio represents a path out of the SARS-CoV-2 pandemic for the US.
Executives mapped out the next few years for the firm, estimating a deceleration in COVID-19 testing beginning the second half of 2021.
BD is reinvesting some of its $668 million Veritor Dx windfall into expanding the menu for a newly tripled installed base.
The University of Birmingham-developed method combines a method called EXPAR with a rapid upfront step to obviate reverse transcription.
The firm is a spinout of a new California-based tech incubator called Murrieta Genomics that aims to provide total support to genomics technology startups.
The firm is also developing an instrument-free molecular diagnostic assay technology for the home testing market.
The firm plans to begin its OTC efforts with a COVID antigen test but also sees potential in migrating other infectious disease tests.
Some tests that detect multiple SARS-CoV-2 genes are serendipitously signaling new viral variants while still effectively detecting infections.
The firm claims a rapid isothermal test has an LoD of 20 viral copies per milliliter while a saliva-based PCR test has an LoD of 2 copies per milliliter.
New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.
According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.
The US National Institutes of Health has a new initiative to address structural racism in biomedical research.
In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.